Abstract
Aside from its actions on glycaemic control, insulin has been demonstrated to have a wide range of effects on the cardiovascular system. During the peri-operative period, the stress response to surgery leads to hyperglycaemia. There is continuing debate with regard to the level of glycaemic control and the potential benefits of insulin therapy in both diabetic and non-diabetic patients undergoing cardiac surgery. This review article sets out to discuss the evidence for glycaemic control, as well as the potential benefits of insulin therapy in the form of glucose-insulin-potassium therapy in cardiac surgery.
Keywords: Cardiac surgery, coronary artery bypass grafting, diabetes, glucose-insulin-potassium, insulin, metabolism.
Current Diabetes Reviews
Title:Insulin Therapy in Cardiac Surgery
Volume: 10 Issue: 4
Author(s): Ashvini Menon and A. M. Ranasinghe
Affiliation:
Keywords: Cardiac surgery, coronary artery bypass grafting, diabetes, glucose-insulin-potassium, insulin, metabolism.
Abstract: Aside from its actions on glycaemic control, insulin has been demonstrated to have a wide range of effects on the cardiovascular system. During the peri-operative period, the stress response to surgery leads to hyperglycaemia. There is continuing debate with regard to the level of glycaemic control and the potential benefits of insulin therapy in both diabetic and non-diabetic patients undergoing cardiac surgery. This review article sets out to discuss the evidence for glycaemic control, as well as the potential benefits of insulin therapy in the form of glucose-insulin-potassium therapy in cardiac surgery.
Export Options
About this article
Cite this article as:
Menon Ashvini and Ranasinghe M. A., Insulin Therapy in Cardiac Surgery, Current Diabetes Reviews 2014; 10 (4) . https://dx.doi.org/10.2174/1573399810666140918120228
DOI https://dx.doi.org/10.2174/1573399810666140918120228 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Patents in Cardiac Resynchronization Therapy
Recent Patents on Biomedical Engineering (Discontinued) New Cell Therapy Using Bone Marrow-Derived Stem Cells/Endothelial Progenitor Cells to Accelerate Neovascularization in Healing of Experimental Ulcerative Colitis
Current Pharmaceutical Design Dystroglycan, A Multifunctional Adaptor Protein for Signal Transduction and A Potential Therapeutic Target
Current Signal Transduction Therapy Role of Iron Deficiency and Overload in the Pathogenesis of Diabetes and Diabetic Complications
Current Medicinal Chemistry Drugs as Possible Triggers of Takotsubo Cardiomyopathy: A Comprehensive Literature Search - Update 2015
Current Clinical Pharmacology Stem Cell Transplantation in Pediatric Leukemia and Myelodysplasia: State of the Art and Current Challenges
Current Stem Cell Research & Therapy Editorial [Hot Topic: Cardiac Cell Therapy: anno 2011 (Executive Guest Editor: Sophie Van Linthout)
Current Pharmaceutical Design Proinflammatory Gene Polymorphisms and Ischemic Stroke
Current Pharmaceutical Design Cellular Senescence in Cardiovascular Diseases: Potential Age-Related Mechanisms and Implications for Treatment
Current Pharmaceutical Design Peroxisome Proliferator-Activated Receptors and the Control of Fatty Acid Oxidation in Cardiac Hypertrophy
Mini-Reviews in Medicinal Chemistry Patent Selections
Recent Patents on Cardiovascular Drug Discovery Determinants of Left Ventricular Hypertrophy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Molecular Aspects of Modulation of L-type Calcium Channels by Protein Kinase C
Current Molecular Pharmacology Effect of β-Blockers on Perioperative Myocardial Ischemia in Patients Undergoing Noncardiac Surgery
Current Drug Targets The Chaperone-like Activity of Rat HspB8/Hsp22 and Dynamic Molecular Transition Related to Oligomeric Architectures In Vitro
Protein & Peptide Letters The Anti-fibrotic Hormone Relaxin is not Reno-protective, Despite Being Active, in an Experimental Model of Type 1 Diabetes
Protein & Peptide Letters Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance?
Current Drug Targets The Role of Mitochondrial Dysfunction in Heart Failure and Potential Therapeutic Targets
Current Pharmaceutical Design Urocortin: Cardiovascular Actions and Therapeutic Implications
Letters in Drug Design & Discovery The ErbB Receptors and their Ligands in Cancer: An Overview
Current Drug Targets